• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SYNTHES GMBH UNK - SCREWS: VA LOCKING; SCREW, FIXATION, BONE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SYNTHES GMBH UNK - SCREWS: VA LOCKING; SCREW, FIXATION, BONE Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Arthritis (1723); Pain (1994); Joint Dislocation (2374)
Event Type  Injury  
Manufacturer Narrative
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If the information is unknown, not available or does not apply, the section/field of the form is left blank.Additional narrative: this report is for an unknown screws: va locking/unknown lot.Part and lot numbers are unknown; udi number is unknown.Complainant part is not expected to be returned for manufacturer review/investigation.Without a lot number the device history records review could not be completed.Product was not returned.Based on the information available, it has been determined that no corrective and/or preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event Description
This report is being filed after the review of the following journal article: sun, c, et al.(2022), lisfranc injuries with dislocation the first tarsometatarsal joint: primary arthrodesis or internal fixation (a randomized controlled trial), international orthopaedics https://doi.(b)(4).The purpose of this study was to compare open reduction and internal fixation (orif) and primary arthrodesis of the first tarsometatarsal joint for lisfranc injuries with the first tarsometatarsal joint dislocation.From january 2016 to january 2021, 78 patients with lisfranc injuries with first tarsometatarsal joint dislocation were randomized to treatment with either open reduction and internal fixation or primary arthrodesis were included in the study.There were 50 males and females with a mean age of 40.7 years.A total of 48 patients were treated with orif and were implanted with an unknown synthes tarsometatarsal bridging plates as well as an unknown manufacturer 2.7 mm cortical screws and an unknown manufacturer k-wires.There were 30 patients who were treated with primary arthrodesis with the exact same approach and principles used as that in performing open reduction and internal fixation.The only additional step was that the articular cartilage was removed from both the surfaces of the first tarsometatarsal joint.Post-operatively, the patients wore a short leg splint for 2 weeks and had a short leg cast for 4 to 6 weeks.Partial weight bearing began at 6 weeks when cast immobilization and the k-wires were removed.Patients were followed at 3 weeks, 6 weeks, 3 months, 6 months, and 12 months postoperatively.For orif group, the bridging plate over the first tarsometatarsal joint was removed as planned between 3 and 4 months post-operatively.Complications were reported as follows: 6 patients had loosened or broken plates.10 patients had redislocation of the first tarsometatarsal joint.6 were asymptomatic and 4 were painful on the midfoot and required revision.15 patients had pain in their midfoot.8 of them had persistent pain with the development of deformity or osteoarthritis, and 4 patients among them were eventually revised with arthrodesis, while the others received conservative treatment such as taking pain killers.2 patients had painful hardware and the symptom disappeared after removal of the hardware.A copy of the literature article is being submitted with this regulatory report.This report involves one unk - screws: va locking.This is report 2 of 2 for (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK - SCREWS: VA LOCKING
Type of Device
SCREW, FIXATION, BONE
Manufacturer (Section D)
SYNTHES GMBH
eimattstrasse 3
oberdorf 4436
SZ  4436
Manufacturer Contact
kate karberg
1302 wright lane east
west chester, PA 19380
3035526892
MDR Report Key15395607
MDR Text Key299663468
Report Number8030965-2022-06590
Device Sequence Number1
Product Code HWC
Combination Product (y/n)N
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/09/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/17/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-